Infusion Related Reaction
94 drugs137,540 FAERS reportsMedDRA PT
GET
/api/v1/reaction/infusion-related-reactionReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Infusion Related Reaction (94)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Picea Mariana Resin150%
- 2Tetrachloroaurate150%
- 3Ublituximab1,39438%
- 4Cortisone4,40736%
- 5Triclosan17334%
- 6Desoximetasone5,96732%
- 7Butyrate51328%
- 8Insulin Icodec125%
- 9Amivantamab66223%
- 10Pemivibart719%
- 11Cupric Oxide11119%
- 12Pseudoephedrine4,08816%
- 13Tarlatamab114%
- 14Zanidatamab614%
- 15Formaldehyde913%
- 16Taurolidine113%
- 17Dimethyl Sulfoxide2812%
- 18Lazertinib6812%
- 19Donanemab23412%
- 20Neomycin74411%
- 21Diatrizoate5811%
- 22Ferumoxytol20111%
- 23Pegloticase36211%
- 24Oritavancin12410%
- 25Sarilumab2,58210%
- 26Exagamglogene Autotemcel310%
- 27Idursulfase3869.8%
- 28Crizanlizumab1319.5%
- 29Sodium Ferric Gluconate Complex1969.3%
- 30Dextran1569.2%
- 31Sodium Succinate4,7528.9%
- 32Lecanemab2838.5%
- 33Tocilizumab9,2948.3%
- 34Calaspargase Pegol558.3%
- 35Sipuleucel-t4538.1%
- 36Infliximab19,3758.1%
- 37Ferric Derisomaltose977.8%
- 38Margetuximab27.7%
- 39Golimumab6,3697.6%
- 40Codeine1,5297.5%
- 41Rolapitant407.4%
- 42Alendronate7,0157.0%
- 43Daratumumab2,6696.5%
- 44Zinc Oxide2016.4%
- 45Dexchlorpheniramine646.4%
- 46Meperidine5716.3%
- 47Taliglucerase Alfa346.1%
- 48Rituximab12,7455.9%
- 49Minocycline9415.8%
- 50Aprepitant1,0115.6%
- 51Imetelstat95.6%
- 52Velmanase Alfa35.6%
- 53Fosaprepitant7155.3%
- 54Obinutuzumab8315.3%
- 55Diphenhydramine9,9615.1%
- 56Hydrocortisone6,1565.1%
- 57Velaglucerase Alfa1025.0%
- 58Ustekinumab5,0425.0%
- 59Isopropyl Alcohol1,6444.9%
- 60Pegunigalsidase Alfa144.7%
- 61Isatuximab2494.7%
- 62Patisiran1284.6%
- 63Mogamulizumab574.5%
- 64Cetirizine7,5984.5%
- 65Iron Sucrose4044.4%
- 66Valerate2804.3%
- 67Sucrose4044.3%
- 68Methylprednisolone7,1464.3%
- 69Triamcinolone1,2834.2%
- 70Desonide2014.2%
- 71Avelumab1453.7%
- 72Ocrelizumab2,1793.6%
- 73Gemtuzumab Ozogamicin1293.6%
- 74Linvoseltamab13.6%
- 75Cetuximab1,0983.6%
- 76Nadolol2663.6%
- 77Alglucosidase Alfa833.5%
- 78Hyaluronidase3343.5%
- 79Telavancin43.4%
- 80Clemastine443.3%
- 81Agalsidase Beta2973.3%
- 82Vestronidase Alfa23.2%
- 83Datopotamab Deruxtecan143.1%
- 84Inebilizumab163.1%
- 85Ertapenem2193.0%
- 86Sebelipase Alfa193.0%
- 87Mirvetuximab Soravtansine433.0%
- 88Dalbavancin322.8%
- 89Axatilimab32.7%
- 90Chlorambucil1002.6%
- 91Nipocalimab42.6%
- 92Palonosetron1572.5%
- 93Relatlimab81.8%
- 94Benzene1—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Rheumatoid Arthritis19 shared · 0.14
- Systemic Lupus Erythematosus14 shared · 0.13
- Joint Swelling18 shared · 0.13
- Hypersensitivity31 shared · 0.12
- Glossodynia11 shared · 0.11
- Pemphigus11 shared · 0.11
- Hepatic Enzyme Increased14 shared · 0.11
- Urticaria23 shared · 0.10
- Wound10 shared · 0.10
- Drug Intolerance16 shared · 0.10
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.